# KOTLER KEVIN

> Institutional holdings reported to the SEC as of Q4 2025 on Form 13F. CIK 1601692. Source: https://holderbook.com/funds/1601692-kotler-kevin/

- Reported value: $427.5M
- Positions: 36
- Weight of the ten largest: 91.7%
- Filed: 2026-02-17

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| STATE STR SPDR S&P 500 ETF T | [SPY](https://holderbook.com/stocks/SPY/) | $238.7M | 0 | 55.8% | 1 |
| AVADEL PHARMACEUTICALS PLC | [AVDL](https://holderbook.com/stocks/AVDL/) | $34.9M | 741,343 | 8.2% | 1 |
| INVESCO QQQ TR | [QQQ](https://holderbook.com/stocks/QQQ/) | $30.7M | 0 | 7.2% | 1 |
| ANGIODYNAMICS INC | [ANGO](https://holderbook.com/stocks/ANGO/) | $22.0M | 1,713,789 | 5.1% | 1 |
| AURINIA PHARMACEUTICALS INC | [AUPH](https://holderbook.com/stocks/AUPH/) | $19.5M | 1,224,846 | 4.6% | 1 |
| OMEROS CORP | [OMER](https://holderbook.com/stocks/OMER/) | $19.3M | 905,635 | 4.5% | 1 |
| NEUROPACE INC | [NPCE](https://holderbook.com/stocks/NPCE/) | $9.7M | 631,468 | 2.3% | 1 |
| MEDIWOUND LTD | [MDWD](https://holderbook.com/stocks/MDWD/) | $6.2M | 337,236 | 1.5% | 1 |
| AXOGEN INC | [AXGN](https://holderbook.com/stocks/AXGN/) | $5.5M | 168,000 | 1.3% | 1 |
| INTEGRA LIFESCIENCES HLDGS C | [IART](https://holderbook.com/stocks/IART/) | $5.3M | 427,445 | 1.2% | 1 |
| ACLARIS THERAPEUTICS INC | [ACRS](https://holderbook.com/stocks/ACRS/) | $5.1M | 1,705,929 | 1.2% | 1 |
| VERTICAL AEROSPACE LTD | [EVTL](https://holderbook.com/stocks/EVTL/) | $5.0M | 939,705 | 1.2% | 1 |
| ORASURE TECHNOLOGIES INC | [OSUR](https://holderbook.com/stocks/OSUR/) | $4.4M | 1,801,446 | 1.0% | 1 |
| LAKEFRONT BIOTHERAPEUTICS NV | [LKFT](https://holderbook.com/stocks/LKFT/) | $2.9M | 90,000 | 0.7% | 1 |
| ELI LILLY & CO | [LLY](https://holderbook.com/stocks/LLY/) | $2.1M | 2,000 | 0.5% | 1 |
| CERUS CORP | [CERS](https://holderbook.com/stocks/CERS/) | $2.1M | 1,011,614 | 0.5% | 1 |
| NIKE INC | [NKE](https://holderbook.com/stocks/NKE/) | $2.0M | 32,000 | 0.5% | 1 |
| TECTONIC THERAPEUTIC INC | [TECX](https://holderbook.com/stocks/TECX/) | $1.7M | 80,000 | 0.4% | 1 |
| CLIMB BIO INC | [CLYM](https://holderbook.com/stocks/CLYM/) | $1.6M | 400,000 | 0.4% | 1 |
| TREACE MED CONCEPTS INC | [TMCI](https://holderbook.com/stocks/TMCI/) | $1.2M | 474,365 | 0.3% | 1 |
| TRISALUS LIFE SCIENCES INC | [TLSI](https://holderbook.com/stocks/TLSI/) | $1.0M | 145,200 | 0.2% | 1 |
| DEXCOM INC | [DXCM](https://holderbook.com/stocks/DXCM/) | $995.5K | 15,000 | 0.2% | 1 |
| VANDA PHARMACEUTICALS INC | [VNDA](https://holderbook.com/stocks/VNDA/) | $882.0K | 100,000 | 0.2% | 1 |
| ALIGN TECHNOLOGY INC | [ALGN](https://holderbook.com/stocks/ALGN/) | $680.7K | 4,359 | 0.2% | 1 |
| ONKURE THERAPEUTICS INC | [OKUR](https://holderbook.com/stocks/OKUR/) | $573.3K | 197,691 | 0.1% | 1 |
| GE AEROSPACE | [GE](https://holderbook.com/stocks/GE/) | $452.2K | 1,468 | 0.1% | 1 |
| PULMONX CORP | [LUNG](https://holderbook.com/stocks/LUNG/) | $442.0K | 200,000 | 0.1% | 1 |
| PTC THERAPEUTICS INC | [PTCT](https://holderbook.com/stocks/PTCT/) | $379.8K | 5,000 | 0.1% | 1 |
| DYCOM INDS INC | [DY](https://holderbook.com/stocks/DY/) | $355.1K | 1,051 | 0.1% | 1 |
| TAKEDA PHARMACEUTICAL CO LTD | [TAK](https://holderbook.com/stocks/TAK/) | $311.8K | 20,000 | 0.1% | 1 |
| BETA BIONICS INC | [BBNX](https://holderbook.com/stocks/BBNX/) | $250.3K | 8,216 | 0.1% | 1 |
| ISHARES TR | [IHI](https://holderbook.com/stocks/IHI/) | $242.5K | 3,902 | 0.1% | 1 |
| BANK OF AMER CORP | [BAC](https://holderbook.com/stocks/BAC/) | $241.6K | 4,392 | 0.1% | 1 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $230.8K | 1,000 | 0.1% | 1 |
| ELANCO ANIMAL HEALTH INC | [ELAN](https://holderbook.com/stocks/ELAN/) | $205.3K | 9,072 | 0.0% | 1 |
| PLIANT THERAPEUTICS INC | [PLRX](https://holderbook.com/stocks/PLRX/) | $113.5K | 93,000 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q4 2025 | $427.5M | 36 |